97635380 - CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA. DIVERSITY, EQUITY, AND INCLUSION

Information

• Trademark
• 97635380

• Source

• Serial Number

  97635380

• International Classifications

  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 17, 2022
  2 years ago

• Transaction Date

  October 14, 2024
  2 months ago

• Status Date

  October 14, 2024
  2 months ago

• Published for Opposition Date

  January 16, 2024
  11 months ago

• Location Date

  March 12, 2024
  9 months ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  MEIER, SHARON

• Attorney Docket Number

  33324/60066

  Attorney Name

  Tiffany D. Gehrke

  Law Office Assigned Location Code

  M30

• Owners

  • Crispr Therapeutics AG

Case File Statements

• GS0411: Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
• DM0000: The mark consists of a double helix to the left of the terms CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION.
• PM0001: CRISPR THERAPEUTICS DE AND I IT IS IN OUR DNA DIVERSITY EQUITY AND INCLUSION
• TF0000: As to "CRISPR THERAPEUTICS"
• CC0000: Color is not claimed as a feature of the mark.
• DS0000: "DE&I" AND "DIVERSITY, EQUITY, AND INCLUSION"
• GS0421: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Case File Event Statements

• 10/20/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/20/2022 - 2 years ago

  2 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/20/2022 - 2 years ago

  3 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/20/2022 - 2 years ago

  4 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/1/2022 - 2 years ago

  5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/2/2022 - 2 years ago

  6 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 3/31/2023 - a year ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 6/30/2023 - a year ago

  11 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 3/31/2023 - a year ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/31/2023 - a year ago

  9 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/31/2023 - a year ago

  10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/30/2023 - a year ago

  12 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 7/18/2023 - a year ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/18/2023 - a year ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/18/2023 - a year ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/12/2023 - a year ago

  16 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/12/2023 - a year ago

  17 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/12/2023 - a year ago

  18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/11/2023 - a year ago

  19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/11/2023 - a year ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/12/2023 - a year ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/13/2023 - a year ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/27/2023 - a year ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/16/2024 - 11 months ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/16/2024 - 11 months ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/12/2024 - 9 months ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/14/2024 - 2 months ago

  27 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/14/2024 - 2 months ago

  28 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6